CIK: 0001019231 · Show all filings
Period: Q2 2023 (← Previous) (Next →)
Filing Date: Aug 4, 2023
Total Value ($000): $259 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| BBRE | JPM BETABLDRS MSCI US REIT | 2,560,948 | $216 | 83.6% | $91.03 | — | ETFS | 46641Q738 |
| — | ELLIOTT OPPORTUNITY II CORP | 2,000,000 | $21 | 8.0% | $10.01 | — | COM | G30092129 |
| IMTX | IMMATICS NV | 697,431 | $8 | 3.1% | $10.53 | -11.4% | COM | N44445109 |
| TXN | TEXAS INSTRUMENTS INC | 32,000 | $6 | 2.2% | $57.24 | +177.9% | COM | 882508104 |
| VT | VANGUARD TOT WORLD STK ETF | 29,585 | $3 | 1.1% | $80.77 | — | ETFS | 922042742 |
| — | HASHICORP INC | 84,182 | $2 | 0.9% | $10.20 | — | COM | 418100103 |
| BOND | PIMCO ACTIVE BOND EXCHANGE-T | 15,502 | $1 | 0.5% | $107.83 | — | COM | 72201R775 |
| DNLI | DENALI THERAPEUTICS INC | 36,513 | $1 | 0.4% | $28.12 | 0.0% | COM | 24823R105 |
| MNDY | MONDAY.COM LTD | 738 | $0 | 0.0% | $149.45 | 0.0% | COM | M7S64H106 |
| — | AEGLEA BIOTHERAPEUTICS INC | 245,678 | $0 | 0.0% | $6.41 | — | COM | 00773J103 |
| LXRX | LEXICON PHARMACEUTICALS INC | 35,714 | $0 | 0.0% | $7.34 | -63.9% | COM | 528872302 |
| — | TFF PHARMACEUTICALS INC | 22,066 | $0 | 0.0% | $18.47 | — | COM | 87241J104 |
| V | VISA INC | 29 | $0 | 0.0% | $224.44 | 0.0% | COM | 92826C839 |
| MA | MASTERCARD INC | 18 | $0 | 0.0% | $369.85 | 0.0% | COM | 57636Q104 |
| ADBE | ADOBE INC | 14 | $0 | 0.0% | $402.84 | 0.0% | COM | 00724F101 |
| POR | PORTLAND GENERAL ELECTRIC CO | 118 | $0 | 0.0% | $20.00 | +118.6% | COM | 736508847 |
| NVDA | NVIDIA CORP | 7 | $0 | 0.0% | $33.17 | 0.0% | COM | 67066G104 |
| AAPL | APPLE INC | 11 | $0 | 0.0% | $172.06 | 0.0% | COM | 037833100 |